The strongest appetite control often develops after several weeks of consistent treatment
Multiple regulatory bodies oversee their operations, including the Utah State Board of Pharmacy, the FDA, the DEA, and state departments of health
40
Participants who took semaglutide (Ozempic) over the course of 68 weeks in a clinical trial lost an average of 15% of their body weight
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy